CEL-SCI
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CEL-SCI and buy or sell other stocks, ETFs, and their options commission-free!About CVM+
CEL-SCI Corp. is a biotechnology company, which engages in the research, development and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS).
CEOGeert R. Kersten, MBA
CEOGeert R. Kersten, MBA
Employees—
Employees—
HeadquartersVienna, Virginia
HeadquartersVienna, Virginia
Founded1983
Founded1983
Employees—
Employees—
CVM+ Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume27.36K
Average volume27.36K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.45
52 Week high$0.45
52 Week low$0.0413
52 Week low$0.0413
Stock Snapshot
The current CEL-SCI(CVM+) stock price is $0.00.
CEL-SCI(CVM+) stock opened on 2025-12-15 at —. The price climbed to — and dipped to —.
CEL-SCI(CVM+) shares are trading with a volume of 0, against a daily average of 27.36K.
During the past year, CEL-SCI(CVM+) stock moved between $0.04 at its lowest and $0.45 at its peak.
During the past year, CEL-SCI(CVM+) stock moved between $0.04 at its lowest and $0.45 at its peak.